Costs of Respiratory Syncytial Virus Hospitalizations in Colombia

• DOI: 10.1007/s41669-020-00218-7
• Publication Date: 2020-05-16T17:02:41Z
• Authors: Jefferson Antonio...; Diana Guerrero Pa...
• Keywords: Medical costs; Medical record

Several clinical practice guidelines exist for the management of respiratory syncytial virus (RSV) infection, but use and overuse medications medical tests with insufficient evidence effectiveness remains substantial. This study aimed to evaluate costs associated bronchiolitis hospitalizations caused by RSV infection among infants aged < 2 years in Colombia. was a prevalence-based cost-of-illness multicentric performed from societal perspective during 2016–2017. A case defined as laboratory-confirmed hospitalization. All resources were collected directly invoices health records. included 193 patients diagnosis RSV. The average hospital stay duration 5.55 days. major contributors hospitalization room (31.5%), drugs (21.8%), indirect (14.9%). Medications highest nebulization hypertonic solution systemic antibiotics. In total, 96% β-lactam antibiotics, 90% bronchodilators, 86% corticosteroids epinephrine classified inappropriate. Colombia places high economic burden on system. Generating comprehensive data healthcare resource will help provide valuable information development cost-effectiveness models guide RSV-prevention strategies.